Prof. Tom F. Lue, MD, ScD (Hon), FACS

Dr. Tom F. Lue is Professor and Vice-Chair of Urology at UCSF. He also is Director of the Knuppe Molecular Urology Laboratory, a recipient of NIH MERIT Award for his translational research in penile physiology and erectile dysfunction. His team discovered the anatomical mechanism of venous compression during penile erection, published the first article implicating TGF beta in the formation of Peyronie’s plaque, and developed the animal models for the study of Peyronie’s disease and stress urinary incontinence. His clinical research "firsts" include authorship of the New England Journal of Medicine paper describing the landmark clinical trial introducing Sildenafil (Viagra®) for erectile dysfunction, and the development of four diagnostic tests for erectile dysfunction: the penile injection and stimulation test, the duplex ultrasound test for penile arterial flow, pharmacologic cavernosography for venous leakage, and the use of duplex ultrasound to diagnose priapism. He also developed seven new surgical procedures for Peyronie’s disease, priapism and erectile dysfunction. He has been the recipient of the American Urological Association's Gold Cystoscope Award and the American Foundation of Urological diseases’ Most Innovative Researcher Award. He Chaired the International Consultation on Sexual Medicine held in Paris in July 2003 serving as lead author of its published proceedings. He was the honorary president of the same meeting in Paris in July, 2009.

Dr. Lue's current basic science research projects involve the development of animal models for research in erectile dysfunction due to hormone deficiency, cavernous nerve injury, diabetes mellitus and hyperlipidemia. Regarding Peyronie’s disease, he is currently testing the hypothesis that prolonged inflammation/autoimmune reaction is involved in the pathogenesis of Peyronie’s disease. His lab also has 10 years of experience in basic cell biology research of mesenchymal stem cells [MSC]. His lab is one of the first to show evidence that MSCs are vascular stem cells existing in various tissues and paracrine effect may be involved in the action of implanted MSC in addition to cellular differentiation. Using animal models, Dr. Lue also is exploring the feasibility of using adipose tissue derived adult stem cells as a source of stem cells for the treatment of stress urinary incontinence, neurogenic impotence and functional recovery after spinal cord injury. The application of MSC in erectile dysfunction is scheduled for clinical trial soon.

Besides being listed in The Best Doctors in America and America’s Top Doctors for many years, he was named one of the 8 top doctors for men by Men’s Health Magazine in 2003. He has published more than 360 peer reviewed articles and more than 100 book chapters. His research team has trained more than 70 postgraduate doctors and most of them are continuing research career in academic institutions in many countries.

Hui Jiang, MD

Hui Jiang, MD, Chief Physician, Level-II Professor (Professors in China fall into 4 levels), doctoral supervisor, and Party Secretary of Peking University First Hospital. Recognized as one of China’s leading experts in andrology and sexual medicine, he is a recipient of the State Council Special Government Allowance. Over the years, he has made major contributions to the rapid development and internationalization of andrology in China, and is a leading figure in public education and health promotion for male reproductive health.

Professor Hui Jiang is one of the first National Health Science Popularization Experts, a core expert on the National Assisted Reproductive Technology Review Panel, and an expert on the National Medical Products Administration's Medical Device Classification Technical Committee. He has published more than 200 academic papers, served as editor or co-editor to more than ten academic works, and authored ten popular science books for the general public. He has led or participated in more than 20 funded research projects, including major projects funded by the National Natural Science Foundation, National Key R&D Program projects of the Ministry of Science and Technology, including projects for which he served as Chief Scientist, projects funded by the National Natural Science Foundation of China, and the Beijing Distinguished Talents Program. He has received eight provincial- and ministerial-level science and technology awards, including the National Award for Excellence in Innovation, the Chinese Medical Science and Technology Award, the Ministry of Education Science and Technology Achievement Award, the Chinese Preventive Medicine Association Science and Technology Award, the Huaxia Medical Science and Technology Award, and the National Maternal and Child Health Science and Technology Award. For his contributions to teaching, he received the first prize of the 2022 National Teaching Achievement Award for Higher Education (Graduate) and has also been honored with Li Dazhao Award, the highest award for Party affairs and ideological-political work at Peking University, as well as the titles of Advanced Individual in National Scientific Literacy Work and National Advanced Worker in the Health System.

Professor Hui Jiang currently serves as the President of the Asia Pacific Society of Sexual Medicine, Vice President of the China Maternal and Child Health Research Association, Vice President of the China Association of Health Promotion and Education, Vice President of the Chinese Research Hospital Association, Director of the Fertility Protection Branch of the Chinese Preventive Medicine Association, Vice President of the Beijing Hospital Association, Vice President of the Beijing Health Education Association, President of the Beijing Medical Association Andrology Society, and Vice Director of the Beijing Medical Association Reproductive Medicine Branch.

He also serves as the Editor-in-Chief of the "The Chinese Journal of Human Sexuality", Deputy Editor of the "Asian Journal of Andrology", Deputy Editor of the "Chinese Journal of Andrology", Deputy Editor of the "Chinese Journal of Reproductive Health", Deputy Editor of the " China Hospital CEO " magazine, Deputy Editor of the "Chinese Hospital Management" magazine, standing committee member of the "Chinese Journal of Family Planning", and editorial board member of the "Reproductive Medicine Journal".

Xuesong Li

Prof. Li received his MD degree from Peking University Health Science Center in 1999 and his PhD degree from the First Hospital of Peking University in 2004. He worked as Attending Doctor of Peking University First Hospital in 2004-2008 and went to UCSF as visiting scholar in 2009-2010.

He is currently the Associate Professor of Peking University First Hospital from 2009. He is also a member of Youth Society of Chinese Urological Association, Vice president of Youth Society of Beijing Urological Association. Fund Evaluation Experts of Beijing Natural Science Foundation, etc.

Prof. Li has been engaged in clinical works, teaching and research on Urology and Andrology fields for more than 20 years. His major research interest focuses on urological oncology and ureter reconstruction . He has authored 100 articles and chapters in peer-reviewed journals and books. He served as a guest editor, editorial member and reviewer for 8 medical and research journals.